Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

   141,861,898      
Direct Value   $82,461,833    

Indirect Value

   $12,984,280,034      
Total Shares   142,789,105      
Total Value   $13,066,741,867      


Incyte Corp $32,925,824 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $318,573 Neurogene $16,634 Incyte Corp $32,925,824 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $318,573 Neurogene $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    36   
    6    

     Stock price went up :
    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 54 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
INCY Incyte Corp Director   –       •       •   2010-09-21 4 S $14.94 $3,559,871 I/I (238,230) 3,091,841 0 -
INCY Incyte Corp Director   –       •       •   2012-01-13 4 B $16.46 $3,595,234 I/I 217,511 12,430,783 2.25 -
VPHM Viropharma Inc 10% Owner   –       –       •   2010-05-06 4 S $12.62 $3,625,407 I/I (286,764) 2,849,035 0 -
SGEN Seagen Inc Director   –       •       •   2009-05-20 4 B $9.72 $3,674,675 I/I 378,053 4,352,809 2.25 -
SGEN Seagen Inc Director   –       •       •   2010-04-30 4 B $12.56 $3,870,283 I/I 306,022 10,552,695 2.25 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2007-12-19 4 B $13.25 $3,949,030 I/I 298,040 1,078,767 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2010-02-10 4 B $16.93 $3,950,924 I/I 231,893 4,168,674 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2007-05-21 4 B $15.50 $4,157,844 I/I 268,248 874,957 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-02-10 4 B $26.52 $4,249,931 I/I 159,832 7,319,618 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2007-06-19 4 S $5.64 $4,297,713 I/I (755,352) 6,073,545 0 -
SGEN Seagen Inc Director   –       •       •   2006-05-24 4 B $5.25 $4,368,709 I/I 832,135 1,515,043 2.25 -
INCY Incyte Corp Director   –       •       •   2010-08-09 4 S $14.08 $4,416,947 I/I (313,622) 8,616,083 0 -
INCY Incyte Corp Director   –       •       •   2011-12-06 4 B $13.52 $4,578,060 I/I 338,406 11,339,120 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-05 4 B $29.96 $4,651,479 I/I 155,014 8,213,837 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2012-01-05 4 A $25.18 $4,723,164 I/I 187,576 1,736,065 0 -
GHDX Genomic Health Inc Director   –       •       •   2012-05-15 4 B $33.11 $4,772,474 I/I 140,000 242,888 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-05-21 4 B $32.04 $4,826,973 I/I 150,000 246,683 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2007-01-29 4 B $6.00 $5,029,776 I/I 838,296 2,557,090 1.5 -
SGEN Seagen Inc Director   –       •       •   2008-01-18 4 B $9.00 $5,040,423 I/I 560,047 3,814,564 2.25 -
INCY Incyte Corp Director   –       •       •   2022-03-09 4 B $71.72 $5,057,550 I/I 70,517 33,217,136 2.25 %
VPHM Viropharma Inc 10% Owner   –       –       •   2010-04-30 4 B $12.76 $5,079,843 I/I 397,943 3,135,799 1.5 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-06-27 4 S $15.41 $5,109,925 I/I (331,598) 601,511 0 -
KOD Kodiak Sciences Inc. Director   –       •       •   2022-02-16 4 B $53.73 $5,150,173 I/I 95,165 14,457,794 2.25 %
INCY Incyte Corp Director   –       •       •   2008-01-08 4 B $10.00 $5,237,901 I/I 482,798 5,270,518 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-02-08 4 B $26.17 $5,294,564 I/I 202,089 7,103,792 2.25 -
  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54  55   56      
  Page 54 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us